RFK Jr. is advocating for the FDA to lift restrictions on over a dozen injectable peptide treatments that were banned in 2023 due to significant safety risks and lack of efficacy data. These unproven peptides are popular among wellness influencers and biohackers for unverified claims like anti-aging and disease treatment. The move highlights ongoing tensions between regulatory caution and alternative health trends.
Background
Peptides are chains of amino acids with various biological functions, and while some like insulin and GLP-1 drugs are FDA-approved, many unproven peptides are marketed online for dubious health benefits. The FDA reclassified several peptides in 2023 due to safety concerns, restricting their compounding.
- Source
- Ars Technica
- Published
- Apr 1, 2026 at 05:51 AM
- Score
- 5.0 / 10